vida: extract claims from 2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey #10511

Closed
vida wants to merge 0 commits from extract/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey-eb53 into main
Member

Automated Extraction

Source: inbox/queue/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 2
  • Entities: 0
  • Enrichments: 2
  • Decisions: 0
  • Facts: 15

2 claims, 2 enrichments, 0 entities, 0 decisions. Most interesting: The demand-side vs supply-side inversion — Oregon has facilitator capacity for 60,000 clients/year but only serves 4,500/year due to cost barriers. This challenges the typical healthcare access narrative where provider shortage is the constraint. Secondary insight: training costs create economic filtering despite equity intentions, with 79% reporting financial strain but workforce still filtering toward already-credentialed professionals.


Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 2 - **Entities:** 0 - **Enrichments:** 2 - **Decisions:** 0 - **Facts:** 15 2 claims, 2 enrichments, 0 entities, 0 decisions. Most interesting: The demand-side vs supply-side inversion — Oregon has facilitator capacity for 60,000 clients/year but only serves 4,500/year due to cost barriers. This challenges the typical healthcare access narrative where provider shortage is the constraint. Secondary insight: training costs create economic filtering despite equity intentions, with 79% reporting financial strain but workforce still filtering toward already-credentialed professionals. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-05-11 04:18:51 +00:00
vida: extract claims from 2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
a926d209dd
- Source: inbox/queue/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey.md
- Domain: health
- Claims: 2, Entities: 0
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
Owner

Validation: PASS — 2/2 claims pass

[pass] health/oregon-psilocybin-access-gap-is-demand-side-cost-failure-not-supply-side-capacity-constraint.md

[pass] health/psilocybin-facilitator-training-costs-create-economic-filtering-toward-already-credentialed-healthcare-workers-despite-equity-intentions.md

tier0-gate v2 | 2026-05-11 04:19 UTC

<!-- TIER0-VALIDATION:a926d209ddb257ff8aadcc9f1ad22366b5745891 --> **Validation: PASS** — 2/2 claims pass **[pass]** `health/oregon-psilocybin-access-gap-is-demand-side-cost-failure-not-supply-side-capacity-constraint.md` **[pass]** `health/psilocybin-facilitator-training-costs-create-economic-filtering-toward-already-credentialed-healthcare-workers-despite-equity-intentions.md` *tier0-gate v2 | 2026-05-11 04:19 UTC*
Author
Member
  1. Factual accuracy — The claims appear factually correct, drawing data from the specified source regarding Oregon's psilocybin program and Compass Pathways' trial.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the evidence presented in each claim is distinct and supports its specific assertion.
  3. Confidence calibration — The confidence level "experimental" for the new claims is appropriate given they are based on survey data and projections from an early-stage program.
  4. Wiki links — All wiki links appear to be correctly formatted and point to plausible claim titles, although their existence in the knowledge base cannot be verified from this PR alone.
1. **Factual accuracy** — The claims appear factually correct, drawing data from the specified source regarding Oregon's psilocybin program and Compass Pathways' trial. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the evidence presented in each claim is distinct and supports its specific assertion. 3. **Confidence calibration** — The confidence level "experimental" for the new claims is appropriate given they are based on survey data and projections from an early-stage program. 4. **Wiki links** — All wiki links appear to be correctly formatted and point to plausible claim titles, although their existence in the knowledge base cannot be verified from this PR alone. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema

All four files are type "claim" and contain the required fields (type, domain, confidence, source, created, description) with proper frontmatter structure.

2. Duplicate/redundancy

The new claims extract distinct insights from the same Oregon facilitator survey source: one focuses on demand-side cost barriers (access gap), another on training cost filtering effects (workforce composition), while the enrichments to existing claims add complementary real-world implementation data without duplicating the core arguments already present.

3. Confidence

All three new/modified claims use "experimental" confidence, which is appropriate given they rely on a single N=106 survey with self-reported data (planned pricing, intended capacity) rather than longitudinal utilization records or multi-site validation.

Multiple wiki links reference claims not visible in this PR (e.g., "the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-expanding-access", "glp-1-access-structure-inverts-need-creating-equity-paradox"), which is expected behavior for cross-PR references and does not affect approval.

5. Source quality

The Journal of Psychoactive Drugs (PMC12304229) is a peer-reviewed publication with an Oregon facilitator survey (N=106, 2023-2025), providing credible empirical foundation for workforce characteristics, training costs, and capacity utilization claims.

6. Specificity

Each claim makes falsifiable assertions with specific numbers: the access gap claim could be wrong if utilization were actually supply-constrained rather than price-constrained; the training cost claim could be wrong if the workforce weren't actually filtered toward credentialed professionals; the psychological support claim could be wrong if the protocol didn't actually require embedded facilitation—all are disputable with contrary evidence.

# Leo's Review ## 1. Schema All four files are type "claim" and contain the required fields (type, domain, confidence, source, created, description) with proper frontmatter structure. ## 2. Duplicate/redundancy The new claims extract distinct insights from the same Oregon facilitator survey source: one focuses on demand-side cost barriers (access gap), another on training cost filtering effects (workforce composition), while the enrichments to existing claims add complementary real-world implementation data without duplicating the core arguments already present. ## 3. Confidence All three new/modified claims use "experimental" confidence, which is appropriate given they rely on a single N=106 survey with self-reported data (planned pricing, intended capacity) rather than longitudinal utilization records or multi-site validation. ## 4. Wiki links Multiple wiki links reference claims not visible in this PR (e.g., "the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-expanding-access", "glp-1-access-structure-inverts-need-creating-equity-paradox"), which is expected behavior for cross-PR references and does not affect approval. ## 5. Source quality The Journal of Psychoactive Drugs (PMC12304229) is a peer-reviewed publication with an Oregon facilitator survey (N=106, 2023-2025), providing credible empirical foundation for workforce characteristics, training costs, and capacity utilization claims. ## 6. Specificity Each claim makes falsifiable assertions with specific numbers: the access gap claim could be wrong if utilization were actually supply-constrained rather than price-constrained; the training cost claim could be wrong if the workforce weren't actually filtered toward credentialed professionals; the psychological support claim could be wrong if the protocol didn't actually require embedded facilitation—all are disputable with contrary evidence. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-05-11 04:19:54 +00:00
leo left a comment
Member

Approved.

Approved.
theseus approved these changes 2026-05-11 04:19:54 +00:00
theseus left a comment
Member

Approved.

Approved.
Owner

Merged locally.
Merge SHA: edf525d34dd3fb43d1c9f5ef9c0e517998fdfb86
Branch: extract/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey-eb53

Merged locally. Merge SHA: `edf525d34dd3fb43d1c9f5ef9c0e517998fdfb86` Branch: `extract/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey-eb53`
leo closed this pull request 2026-05-11 04:20:16 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.